Drug delivery, Financing, Pharma

Civitas in $38 million series B financing

Posted on 12 September 2013

Tags: , , ,

Civitas Therapeutics announced the successful completion of a $38 million Series B financing round.

Bay City Capital led the series B financing round and was joined by new investors RA Capital and another undisclosed blue chip public investment fund with participation from all existing investors including Alkermes plc, Canaan Partners, Fountain Healthcare Partners, and Longitude Capital.

Civitas plans to use the proceeds from this series B financing for late stage clinical development of the company’s lead program, CVT-301, an inhaled formulation of levodopa being developed for the rapid and reliable relief from debilitating motor fluctuations associated with Parkinson’s disease.

Civitas recently initiated a Phase 2b clinical study to evaluate the efficacy and safety of CVT-301, self-administered by patients, in treating emergent OFF episodes during one month of continued use.

The company will report preliminary data from this study in the first half of 2014.

In addition, Civitas will explore additional opportunities to leverage the ARCUS platform for other disease states where the potential to deliver a large, precise dose of a drug - independent of inspiratory flow rate - from a simple, breath actuated device, would provide a significant clinical advantage.

Related

Report: Parkinson's Disease Partnering

View: Current Partnering’s Financing Scorecard – view top life science financing deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new1gif
rauconbadgejpg
a1banner300x150animgif